Nymox Pharmaceutical Corp (NYMX) Reports Q1 EPS of $0.07

Nymox Pharmaceutical Corp (NASDAQ: NYMX) reported Q1 EPS of $0.07, versus ($0.03) reported last year. Revenue for the quarter came in at $78.16 thousand, versus $184.25 thousand reported last year.

For earnings history and earnings-related data on Nymox Pharmaceutical Corp (NYMX) click here.

You May Also Be Interested In

• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
• Enhanced Group Inc. (ENHA) Reports Q2 Loss of $0.53
• Immucell Corp (ICCC) Reports Q2 EPS of $0.20